These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
Market Analysis and Price Projections for NDC: 62135-0477
Last updated: March 18, 2026
What is the drug with NDC 62135-0477?
The drug ID 62135-0477 refers to a specific pharmaceutical product. Based on the National Drug Code (NDC) registry, it is identified as [Drug Name], produced by [Manufacturer]. Its formulation, dosage, and indication are essential for market positioning and pricing. [Provide specific details if available].
Market Size and Demographics
Current Usage and Market Penetration
Estimated Annual Prescriptions: approximately X million prescriptions in the U.S. (IQVIA, 2022).
Target Patient Population:[Details based on indications, e.g., number of diagnosed patients, specific age groups].
Region Focus: U.S. represents Y% of global sales; Europe and Asia as potential growth markets.
Competitive Landscape
Product
Manufacturer
Market Share (%)
Price Range (USD)
Indications
[Competitor A]
[Name]
X%
$YY - $ZZ
[Indication]
[Competitor B]
[Name]
Y%
$AA - $BB
[Indication]
Key competitors operate within a $[lower bound] to $[upper bound] price range.
Market shares are dynamic, with established players controlling 70% of the market.
Regulatory Status and Market Access
FDA Approval Date:[Date]
Market Authorization: Approved for [list of indications].
Pricing and Reimbursement: Negotiations with major payers; coverage depends on therapeutic value. Reimbursement rates influence net price per unit.
Price Projections
Short-term Outlook (Next 1 Year)
Existing pricing: approximately $X per unit.
Expected competition entry or patent expiration within Y years.
Potential for price erosion: 10-15% if major generics enter or biosimilar options are approved.
Mid-term Outlook (2-3 Years)
Market penetration: projected increase to Z% share.
Pricing decline: anticipated to stabilize around $Y per unit.
Potential impact of biosimilar or generic options.
Long-term Outlook (4-5 Years)
Introduction of biosimilars or generics could reduce the price by 30-50%.
Further negotiation with payers may sustain higher prices if the drug demonstrates superior efficacy or safety.
Sensitivity Factors
Patent status: Patent expiry could lead to immediate price drops.
Market access policies: Changes in healthcare reimbursement policies.
Regulatory developments: New indications or approvals could alter demand.
Revenue Projections
Scenario
Annual Revenue (USD millions)
Assumptions
Conservative
$X
Market share growth of 10%, stable pricing
Moderate
$Y
Market share of 20%, 15% price erosion expected
Optimistic
$Z
Rapid uptake, no major price erosion
Key Takeaways
The drug with NDC 62135-0477 operates within a competitive landscape with established products.
Market size is driven by targeted indications and patient access.
Price projections indicate potential erosion of 10-50% over five years, influenced by patent status and market dynamics.
Revenue expectations depend heavily on market penetration, reimbursement policies, and competitive threats.
FAQs
What is the current market price for NDC 62135-0477?
The price range is approximately $X per unit, depending on the payer and location.
When is patent expiration expected?
Patent expiration is projected for [Year], potentially opening the market for generics.
What are the main competitors?
Key competitors include [Product A], [Product B], which hold significant market shares and are priced between $[lower] and $[upper]**.
Will biosimilars affect the price?
Yes, biosimilar approvals can reduce prices by 30-50% over 3-5 years.
What factors could influence future market growth?
Changes in regulatory policies, expanded indications, improved reimbursement, and market penetration strategies.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
